BlackRock Advisors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$3.5M Sell
64,000
-1,014,863
-94% -$57.6M ﹤0.01% 1279
2016
Q3
$70.9M Buy
1,078,863
+1,014,863
+1,586% +$66.3M 0.08% 267
2016
Q2
$3.86M Hold
64,000
﹤0.01% 1209
2016
Q1
$3.6M Sell
64,000
-87,303
-58% -$5.25M ﹤0.01% 1216
2015
Q4
$10.3M Sell
151,303
-650,175
-81% -$42.6M 0.01% 816
2015
Q3
$51M Sell
801,478
-572,668
-42% -$37.7M 0.06% 298
2015
Q2
$87.5M Sell
1,374,146
-51,225
-4% -$3.51M 0.1% 216
2015
Q1
$97.5M Buy
1,425,371
+126,545
+10% +$8.79M 0.1% 216
2014
Q4
$91.4M Buy
1,298,826
+738,220
+132% +$52.9M 0.1% 234
2014
Q3
$40M Sell
560,606
-4,606
-0.8% -$337K 0.04% 394
2014
Q2
$42M Sell
565,212
-1,522,996
-73% -$110M 0.04% 395
2014
Q1
$135M Sell
2,088,208
-76,292
-4% -$4.93M 0.13% 181
2013
Q4
$129M Buy
2,164,500
+829,800
+62% +$45.1M 0.13% 192
2013
Q3
$69.3M Buy
1,334,700
+338,600
+34% +$17M 0.07% 279
2013
Q2
$47.1M Buy
+996,100
New +$50.7M 0.05% 326

Other funds holding AZN